Dermalogica announced the official launch of the PRO Pen Microneedling System, marking the brand's first FDA-cleared device and its expansion into advanced in-office treatment technologies. The PRO Pen Microneedling System is a microneedling device and accessories intended to be used as a treatment to improve the appearance of facial acne scars in adults aged 22 years and older.
Following FDA clearance, the PRO Pen is now available to licensed skin health professionals, reinforcing Dermalogica's commitment to supporting professionals and consumers with solutions that connect in-office treatments to long-term skin health outcomes. "Dermalogica has always been part of a professional ecosystem that bridges professional in-office treatments with at-home skincare," says Aurelian Lis, CEO of Dermalogica. "The PRO Pen extends this integration, enabling providers to design more comprehensive treatment journeys that support consistent outcomes while strengthening client loyalty and lifetime value. As demand for minimally invasive, results-driven treatments like microneedling continues to grow, consumers are increasingly seeking personalized solutions that connect in-office care with at-home maintenance. Meeting those expectations is central to how we continue to innovate for providers and their patients."
The PRO Pen Microneedling System is designed to support safety, quality, and professional confidence in microneedling procedures. The device is validated for controlled skin penetration and manufactured in accordance with medical device standards, including the use of biocompatible materials intended for safe contact with the skin. As part of Dermalogica's professional offering, the PRO Pen integrates with the brand's established portfolio of professional treatments and at-home skincare, enabling providers to expand service offerings while connecting in-office procedures with prescribed homecare. This approach supports more complete treatment plans for consumers, extending results beyond the treatment room while encouraging client retention and creating additional revenue opportunities for providers through ongoing skincare regimens.